about
Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain managementNew treatments for cocaine dependence: a focused reviewReduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addictionBinding properties of a highly potent and selective iodinated aminopeptidase N inhibitor appropriate for radioautographyAminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesicsNrxn3 upregulation in the globus pallidus of mice developing cocaine addictionSelf-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependenceTransfer of neuroplasticity from nucleus accumbens core to shell is required for cocaine reward.Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120.Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs.Pharmacology of CCKRs and SAR studies of peptidic analog ligands.Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice.Opioid receptor desensitization: mechanisms and its link to toleranceEffects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward.Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors.Temporal regulation of peripheral BDNF levels during cocaine and morphine withdrawal: comparison with a natural reward.Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatmentThe opioid receptors as targets for drug abuse medicationAnalysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profileShort- and long-lasting behavioral and neurochemical adaptations: relationship with patterns of cocaine administration and expectation of drug effects in ratsMethadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependence.[Acute and long-term effects of ecstasy].Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.Sensitization to the conditioned rewarding effects of morphine modulates gene expression in rat hippocampus.Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.Regulation of genes involved in dopamine transporter modulation by acute cocaine in rat striatum.Comparison of tolerance to morphine-induced respiratory and analgesic effects in mice.Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study.Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs.Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study.Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.Depressant effect on a C-fibre reflex in the rat, of RB101, a dual inhibitor of enkephalin-degrading enzymes.
P50
Q28188715-EF6555C5-DB42-4DC9-A207-1565E2C2E5AAQ28252765-EF947D8B-B6B9-4CB2-B1A4-F38FB6998EDEQ28363073-07EAD42A-2115-4468-8FB4-514486E5F167Q28369837-8CE43DFE-0FD4-44AD-A625-B488AE29516CQ28588212-1761B004-A953-488C-9BF5-8E75DEC5B677Q33328806-6F3112E5-C237-4788-810A-173DE03C6B7AQ33790389-70B481E8-2399-4F0E-910E-AC335711845CQ34137604-9858B8EC-1D2B-4789-88D4-B0F5DAF389BEQ34327955-C243138D-DED7-4A03-B5B2-C3FA4A90BEFEQ34456912-A47EE1E6-C41D-43B3-8207-E43C5207D07BQ34602588-E2CAB31A-CCB3-49AF-A08F-28D759ACA6C5Q34640333-4CD122EA-61C8-483C-8C53-3C7020B9D5E7Q34695546-3C84DB1C-B22A-4424-BF21-4A2399B58CD2Q34729984-AAE42DAF-8D05-4CD9-968E-2365B64891DEQ34788170-36179F57-D5FA-4EAC-B0EE-4EDE3BA587C1Q34930511-32DB24D8-55D5-4B8C-9077-6AB49524AAD7Q35224283-B8806E05-0BCE-4417-821C-E0CFEC4C0728Q35873383-6D38A46A-3193-4F08-BB8B-7E30B66F582DQ35978068-8A2E313A-F911-4E8A-96C4-6F30CD9C1854Q36012516-377AED80-397F-4C20-A7E0-B511E2307AC0Q36020861-B30CBD88-C170-447C-B4F3-6A56422F3489Q36591353-1CAE64D9-AAA9-407F-AF1B-5E868D663777Q37137778-F10923C9-1052-4474-92FA-A82A0D20824DQ39027831-15A6A00C-42A6-472E-9091-3950A1E5B118Q40518413-A59E84F1-8EF7-4354-95BA-3D1F30782D3FQ41556993-3387BDD0-08DD-481A-8333-F562717D1B02Q42135507-8B7CF9A7-84A8-4D1F-8DF0-4774A13B6D31Q42143504-0BBC62B7-6B77-4062-9988-D36098017343Q42256324-FB2D7FB6-6816-4767-BE1B-C9BD727CAAFDQ42377030-FCDCD94B-4876-45D6-B938-10F7AF086793Q42713462-59AA28D9-9AA7-4A01-9BAD-76FA832728A9Q43157808-3E762424-A3AC-438F-B18E-6971F1637F8FQ43222855-104D0CD8-B8C9-4C3F-90A1-A16F0A035CB9Q43271212-0D2AE5CE-1350-403B-8C43-61D31914DFD2Q43612688-71B36207-2EA9-4834-A377-568A36CDB0B2Q43755668-63B82A19-A231-42DF-81D2-4FEC97874515Q43875627-DF2D766A-A3BF-4E81-8CB1-40396E0A9BA1Q43907027-49EC4BBA-11E3-4CDB-BBBA-4A861CDB6DB4Q44026805-5EB9CB09-F3C6-4C0F-ACA8-CF2BE01013EEQ44038445-4249799F-9667-4CDC-BD00-339AA17FC936
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Florence Noble
@ast
Florence Noble
@en
Florence Noble
@es
Florence Noble
@nl
type
label
Florence Noble
@ast
Florence Noble
@en
Florence Noble
@es
Florence Noble
@nl
prefLabel
Florence Noble
@ast
Florence Noble
@en
Florence Noble
@es
Florence Noble
@nl
P106
P31
P496
0000-0003-4497-0212